Viridian Therapeutics, Inc.
VRDN
$13.13
$0.483.79%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 50.32% | 140.65% | 70.92% | 64.02% | 12.44% |
Total Receivables | -- | -86.27% | -- | -20.31% | 0.00% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 131.81% | 31.44% | -13.74% | 57.02% | 38.11% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 51.80% | 136.96% | 67.95% | 63.83% | 12.83% |
|
|||||
Total Current Assets | 51.80% | 136.96% | 67.95% | 63.83% | 12.83% |
Net Property, Plant & Equipment | 2.96% | 0.96% | -15.49% | -1.64% | 13.83% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -17.05% | -32.46% | -44.34% | -43.48% | -38.49% |
Total Assets | 51.38% | 134.79% | 66.63% | 63.04% | 12.72% |
|
|||||
Total Accounts Payable | -4.29% | 69.69% | -24.03% | -66.01% | -84.27% |
Total Accrued Expenses | 93.52% | 86.03% | 27.55% | 7.93% | 27.88% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -39.15% | -28.26% | 332.79% | 14.91% | 37.52% |
Total Finance Division Other Current Liabilities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Current Liabilities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Current Liabilities | 79.74% | 77.93% | 28.28% | -11.70% | -20.13% |
|
|||||
Total Current Liabilities | 79.74% | 77.93% | 28.28% | -11.70% | -20.13% |
Long-Term Debt | 1.87% | 2.62% | 271.35% | 334.64% | 334.98% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 104.65% | 67.65% | 15.90% | -6.28% | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -50.44% | -44.81% | -47.87% | -42.66% | -71.82% |
Total Liabilities | 46.20% | 42.55% | 58.17% | 32.58% | 20.92% |
|
|||||
Common Stock & APIC | 53.85% | 77.50% | 47.58% | 49.93% | 29.62% |
Retained Earnings | -37.19% | -39.01% | -37.30% | -39.21% | -48.70% |
Treasury Stock & Other | -102.96% | 1,556.25% | -213.87% | -110.92% | 186.67% |
Total Common Equity | 104.99% | 248.85% | 82.17% | 77.53% | -6.88% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -8.54% | 40.01% | 48.03% | 48.03% | 45.28% |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -8.54% | 40.01% | 48.03% | 48.03% | 45.28% |
|
|||||
Total Common Equity | 104.99% | 248.85% | 82.17% | 77.53% | -6.88% |
Total Preferred Equity | -8.54% | 40.01% | 48.03% | 48.03% | 45.28% |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 51.95% | 149.49% | 67.59% | 66.18% | 11.89% |
|